-
Output registration medical library Amsterdam UMC
-
Alzheimer's diagnosis shortly based on biomarkers At the International Alzheimer's Congress (AAIC) 2023 in Amsterdam, new guidelines for diagnosing Alzheimer's disease developed by clinicians and researchers from around the world were presented. In these criteria, the disease is diagnosed in the clinic through the use of blood biomarkers, just as with other major diseases such as diabetes and cardiovascular disease.
-
Health problems don't recognise borders A land border can't stop a virus. That was clear for everyone as the COVID-19 pandemic spread rapidly across the globe. Only international cooperation can lead to better global healthcare worldwide, something which in the interest of us all. The Global Health department of Amsterdam UMC has spent years trying to drive this forward.
-
Keyhole surgery safe and less invasive for patients with pancreatic cancer Thanks to a large international study, keyhole surgery has been shown to be a safe and less invasive option for pancreatic cancer patients undergoing surgery. These results are published today in The Lancet Regional Health Europe. Professor Mohammad Abu Hilal, from the University of Southampton and a surgeon in Brescia, Italy: “the biggest news is that we now have strong scientific evidence that keyhole surgery is safe for left-sided pancreatic cancer.”
-
Amsterdam UMC led eHealth app ensures faster recovery after major abdominal operations Through the use of eHealth application ikHerstel, patients recover from major abdominal operations 30% faster than patients who do not use the app. That is the main conclusion of research led by Amsterdam UMC across eleven Dutch hospitals. The app aims to empower patients to feel more in control of their recovery process. The results were published today in Lancet Digital Health.
-
New drug application doubles rates of remission in patients with Ulcerative Colitis A new drug, investigated by Amsterdam UMC together with colleagues around the world in universities and the industry, is effective as a treatment against ulcerative colitis. With the clinical trial demonstrating a doubling in the rates of remission, to up to 50%, in certain groups. The results of this clinical trial are, today, published in the New England Journal of Medicine.
-
Customised treatment for heart failure patients through the use of AI Heart failure is the leading cause of hospitalisation in those over 65 and research predicts that the condition will increase in global prevalence by almost 50% by 2030. In order to reduce the burden of disease on both health systems and patients, Amsterdam UMC is launching, thanks to a Horizon Europe grant of almost 6 million euros, a consortium to look for an AI-powered solution.
-
Amsterdam UMC to lead global hunt for new interventions in the battle against unhealthy behaviour Chronic diseases (NCDs) are a global health epidemic and almost 80% of them occur in low- and middle-income countries. In order to combat this, thanks to a Horizon Europe grant, Amsterdam UMC is set to lead a global consortium with the aim of developing interventions that work in practice.
-
Obesity impairs the brain's response to nutrients Brain responses to specific nutrients are diminished in individuals with obesity and are not improved after weight loss, according to a study led by Amsterdam UMC and Yale University, published today in Nature Metabolism.
-
Bottom reached in restrictive blood transfusion policy The trend in hospitals and guidelines is to be more and more cautious with blood transfusions. Due to side effects associated with blood transfusion and the increasing scarcity and costs of blood products. For example, in recent years the number of patients receiving a transfusion during their ICU admission has halved. Researchers from Amsterdam UMC, in collaboration with eight other Dutch hospitals and funded ZonMW, have shown that being increasingly restrictive in preventive blood transfusion is not, in all cases, understandable. The results of this study are published today in the New England Journal of Medicine.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- 99
- 100
- 101
- 102
- 103
- 104
- 105
- 106
- 107
- 108
- 109
- 110
- 111
- 112
- 113
- 114
- 115
- 116
- 117
- 118
- 119
- 120
- 121
- 122
- 123
- 124
- 125
- 126
- 127
- 128
- 129
- 130
- 131
- 132
- 133
- 134
- 135
- 136
- 137
- 138
- 139
- 140
- 141
- 142
- 143
- 144
- 145
- 146
- 147
- 148
- 149
- 150
- 151
- 152
- 153
- 154
- 155
- 156
- 157
- 158
- 159
- 160
- 161
- 162
- 163
- 164
- 165
- 166
- 167
- 168
- 169
- 170
- 171
- 172
- 173
- 174
- 175
- 176
- 177
- 178
- 179
- 180
- 181
- 182
- 183
- 184
- 185
- 186
- 187
- 188
- 189
- 190
- 191
- 192
- 193
- 194
- 195
- 196
- 197
- 198
- 199
- 200
- 201
- 202
- 203
- 204
- 205
- 206
- 207
- 208
- 209
- 210
- 211
- 212
- 213
- 214
- 215
- 216
- 217
- 218
- 219
- 220
- 221
- 222
- 223
- 224
- 225